Evaluation of imaging, clinical and pathological factors associated with 2-year biochemical recurrence in surgical patients with intermediate- to high-risk prostate cancer: a focus on 68Ga-PSMA PET and pelvic 3Tesla mpMRI

Monica Celli¹, Roberta Gunelli², Fabio Ferroni¹, Umberto Salomone³, Cristiano Salaris³, Paola Caroli¹, Eugenia Fragalà³, Lorenzo Fantini¹, Virginia Rossetti¹, Ugo De Giorgi¹, Domenico Barone¹, Valentina Di Iorio¹, Federica Matteucci¹

¹ Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST IRCCS (Meldola )
² Ospedale Morgagni-Pierantoni – AUSL della Romagna, UO Urologia (Forlì)
³ Ospedale Morgagni-Pierantoni, AUSL Romagna, UO Urologia (Forlì)

Argomenti: Cancro della prostata